Dr. Piper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-724-4600Fax+1 617-975-5665
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 2015 - 2018
- University of Massachusetts Medical SchoolClass of 2015
Certifications & Licensure
- MA State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 11 citationsOsimertinib in NSCLC With Atypical-Activating Mutations: A Retrospective Multicenter Study.Jingran Ji, Jacqueline V Aredo, Andrew Piper-Vallillo, Laura Huppert, Julia K Rotow
JTO Clinical and Research Reports. 2023-03-01 - 2 citationsThe ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.Allison E B Chang, Andrew J Piper-Vallillo, Raymond H Mak, Michael Lanuti, Alona Muzikansky
The Oncologist. 2024-07-05 - 20 citationsInsulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).Andrew J. Piper, Jennifer L. Clark, Jose Mercado-Matos, Asia N. Matthew-Onabanjo, Chung-Cheng Hsieh
Plos One. 2019-08-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: